A panel of healthcare experts, Declan Hamill, Christian Ouelett, Laura Syron and Joan Weir, discuss the complexities of Canada’s new PharmaCare legislation, exploring its potential impact on patients, pharmaceutical industries, and healthcare systems. Key topics include drug access, cost implications, provincial negotiations, and the future of drug coverage. Featuring insights from leaders in diabetes, pharmaceuticals, insurance, and healthcare policy.

Highlights:
– First look at Bill C-64’s potential consequences
– Patient perspectives on medication access
– Industry challenges and opportunities
– Provincial variations in drug coverage

#CanadianPharmaCare #HealthcareReform #MedicationAccess #PatientCoverage #DrugPolicyCanada